Overview
Infective endocarditis (IE) involving the left ventricular wall is a rare but severe complication of cardiac infection, often associated with significant morbidity and mortality. Traditionally, IE is predominantly recognized in relation to valvular structures; however, involvement of the left ventricular myocardium represents a more complex clinical scenario. This condition is increasingly identified due to advancements in diagnostic imaging techniques such as echocardiography, computed tomography (CT), and magnetic resonance imaging (MRI), alongside demographic shifts towards an aging population. The epidemiology, clinical presentation, diagnosis, management, complications, and prognosis of left ventricular wall IE are critical areas requiring focused clinical attention. This guideline synthesizes current evidence to provide clinicians with a comprehensive understanding of managing this challenging condition.
Epidemiology
The incidence of infective endocarditis involving the left ventricular wall remains relatively low compared to valvular IE, but it poses significant clinical challenges. A notable study from Saga University Hospital spanning from 2007 to 2017 analyzed 82 patients with positive blood culture results, revealing that 35 (42.7%) were infected with Staphylococcus aureus, underscoring the pathogen's prevalence in this subset of IE [PMID:32536676]. This finding aligns with broader trends where S. aureus is a common causative agent in severe forms of IE. The aging demographic in Japan, coupled with enhanced diagnostic capabilities, necessitates updated clinical studies to better characterize the evolving epidemiology of left ventricular wall IE. These advancements in imaging technology have likely contributed to earlier and more accurate diagnoses, potentially influencing the observed patterns of infection and patient outcomes [PMID:32536676].
Clinical Presentation
Patients with left ventricular wall IE often present with a wide array of symptoms that can obscure the underlying cardiac pathology, frequently leading to initial evaluations in non-cardiovascular departments. Common manifestations include fever, malaise, and nonspecific symptoms such as dyspnea and chest pain, which can mimic other systemic illnesses [PMID:32536676]. The varied clinical presentation underscores the importance of maintaining a high index of suspicion for IE in patients with unexplained systemic signs of infection, especially those with predisposing factors such as valvular disease, prior cardiac surgery, or intravenous drug use. Early recognition is crucial, as delays in diagnosis can lead to progressive myocardial damage and systemic complications. In clinical practice, a thorough history and physical examination, coupled with targeted diagnostic testing, are essential to identify these patients early [PMID:32536676].
Diagnosis
Accurate diagnosis of left ventricular wall IE is pivotal for timely intervention and improved outcomes. Echocardiography remains a cornerstone in the diagnostic workup, with the study indicating that it was performed in 54.9% of patients meeting major modified Duke's criteria, highlighting its utility despite the rarity of the condition [PMID:32536676]. Transthoracic echocardiography (TTE) often provides initial clues, but transesophageal echocardiography (TEE) may be necessary for definitive visualization of myocardial involvement. Beyond echocardiography, advanced imaging modalities such as 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) have emerged as valuable tools in diagnosing cardiac infections, including left ventricular wall IE [PMID:30826023]. These imaging techniques can offer metabolic activity insights that complement anatomical findings, aiding in the differentiation of active infection from sterile inflammation. However, the authors caution that 18F-FDG PET/CT has specific challenges, such as false positives due to inflammation or malignancy, which necessitate careful interpretation and standardized protocols to mitigate diagnostic pitfalls [PMID:30826023].
Management
The management of left ventricular wall IE typically involves a multidisciplinary approach, with infectious disease specialists playing a crucial role in guiding therapy. At Saga University Hospital, the Division of Infectious Disease oversees the selection of appropriate antibiotics and duration of treatment tailored to the specific pathogen identified, often emphasizing the need for prolonged therapy to ensure eradication of infection [PMID:32536676]. Surgical intervention may be required in cases where medical management fails or in patients with significant myocardial dysfunction or abscess formation. A retrospective review of 94 patients undergoing heart valve surgery for infective endocarditis highlights the complexities and outcomes associated with surgical management [PMID:25432198]. Postoperative outcomes revealed an overall hospital mortality rate of 8.5% at 30 days, with low cardiac output syndrome post-surgery identified as a significant independent predictor of early mortality [PMID:25432198]. Surgical strategies varied, with mechanical valves being implanted in 75.5% of cases, biological prostheses in 13.8%, and reconstructive or other procedures in 10.7%, reflecting the tailored approach based on patient-specific factors and residual cardiac function [PMID:25432198].
Key Therapeutic Considerations
Complications
Left ventricular wall IE can lead to a spectrum of serious complications that impact both short-term and long-term outcomes. One critical complication highlighted in the literature is the development of postoperative low cardiac output syndrome, which was identified as an independent predictor of early mortality (p=0.01) in patients undergoing surgical intervention for IE [PMID:25432198]. This syndrome can exacerbate hemodynamic instability, necessitating intensive care support and potentially influencing surgical outcomes adversely. Additionally, the systemic nature of IE can precipitate embolic events, heart failure, and sepsis, further complicating patient management and prognosis [PMID:25432198].
Prognosis & Follow-up
The long-term prognosis for patients with left ventricular wall IE is influenced by both cardiac and extracardiac factors. The retrospective study by [PMID:25432198] revealed an overall late mortality rate of 25.6%, with a cumulative rate of 4.03% per patient-year, primarily attributed to factors outside the heart, such as comorbidities like diabetes mellitus [PMID:25432198]. Postoperative low cardiac output syndrome emerged as another significant predictor of adverse outcomes, underscoring the importance of meticulous postoperative care. Despite these challenges, the cumulative survival rate at 12 years was reported at 57.2%, suggesting that with appropriate management, outcomes can approximate those seen in elective valve replacement surgeries [PMID:25432198]. Regular follow-up is essential to monitor for late complications, manage comorbidities, and ensure sustained cardiac function, thereby optimizing long-term survival and quality of life.
Follow-Up Recommendations
Key Recommendations
References
1 Yamashita S, Tokushima M, Nakashima T, E Katsuki N, Tago M, Yamashita SI. Clinical Status Quo of Infective Endocarditis in a University Hospital in Japan: A Single-hospital-based Retrospective Cohort Study. Internal medicine (Tokyo, Japan) 2020. link 2 Millar BC, de Camargo RA, Alavi A, Moore JE. PET/Computed Tomography Evaluation of Infection of the Heart. PET clinics 2019. link 3 Spiliopoulos K, Giamouzis G, Haschemi A, Karangelis D, Antonopoulos N, Fink G et al.. Surgical management of infective endocarditis: early and long-term mortality analysis. single-center experience and brief literature review. Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese 2014. link